Founders Capital Management (Texas)’s Greenwich LifeSciences GLSI Stock Holding History

Founders Capital Management (Texas)’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$10.5K	–	406
2025 Q4	$10.5K	Hold	500	–	–	0.01%	308
2025 Q3	$4.97K	Hold	500	–	–	﹤0.01%	331
2025 Q2	$4.54K	Hold	500	–	–	﹤0.01%	321
2025 Q1	$4.77K	Hold	500	–	–	﹤0.01%	308
2024 Q4	$5.62K	Hold	500	–	–	﹤0.01%	302
2024 Q3	$7.18K	Hold	500	–	–	﹤0.01%	304
2024 Q2	$8.63K	Hold	500	–	–	0.01%	288
2024 Q1	$9.97K	Hold	500	–	–	0.01%	288
2023 Q4	$5.26K	Hold	500	–	–	﹤0.01%	328
2023 Q3	$4.42K	Hold	500	–	–	﹤0.01%	348
2023 Q2	$4.82K	Hold	500	–	–	﹤0.01%	344
2023 Q1	$7K	Sell	500 -500	-50%	-$7.93K	0.01%	336
2022 Q4	$15K	Hold	1,000	–	–	0.01%	262
2022 Q3	$9K	Hold	1,000	–	–	0.01%	304
2022 Q2	$8K	Buy	+1,000	New	+$11.5K	0.01%	338

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Founders Capital Management (Texas)'s GLSI Position: Q1 2026 in Review

Founders Capital Management (Texas) sold out of Greenwich LifeSciences (GLSI) in Q1 2026, closing a stake of 500 shares — an estimated $10.5K sold.

Founders Capital Management (Texas) first reported a position in GLSI in Q2 2022 and held it in 15 quarters. The position peaked at $15K in Q4 2022. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Founders Capital Management (Texas) reported no remaining Greenwich LifeSciences position as of Q1 2026 after selling out during the quarter.
Founders Capital Management (Texas) sold 500 Greenwich LifeSciences shares in Q1 2026, an estimated $10.5K.
Founders Capital Management (Texas) first reported a position in Greenwich LifeSciences in Q2 2022 and held it in 15 quarters.
Founders Capital Management (Texas)'s Greenwich LifeSciences position peaked at $15K in Q4 2022.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2026, filed 21 Apr 2026.